News & Press Releases

Reinforcing Yseop’s unique footprint in the GenAI space for BioPharma, a new investment enables Yseop to expand the scope of its Generative AI offerings and accelerate its leadership position in life sciences.
Reinforcing Yseop’s unique footprint in the GenAI space for BioPharma, a new investment enables Yseop to expand the scope of its Generative AI offerings and accelerate its leadership position in life sciences.
Yseop is thrilled to announce that we have been nominated for The World Technology Leader Award. We are in the company of prestigious nominees including OpenAI, BMW, and BASF.
Reimagining the future of scientific writing, Yseop Copilot leverages pre-trained cutting edge Generative AI models (LLMs) for the BioPharma industry.
Yseop has won at the 2023 Citeline Awards for Best Use of Artificial Intelligence in Clinical Trials.
Yseop has been honored as a finalist in the 2023 Global Business Tech Awards for the Best Use of Artificial Intelligence in Clinical Trials.
Scroll to Top